Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

168 evidence items · page 1 / 7

95 %At day 14 after diagnosis, MPXV tests were negative or weakly positive in 20 (95%) of 21 urine samples.

NigeriampoxHAL · Unilimdocument of 102 observations

29 %MPXV detection was observed in 13 of 45 blood samples (29%).

NigeriampoxHAL · Unilimdocument of 102 observations

9 %At day 14, MPXV detection in anus was two [9%] of 22.

Nigeriampoxobserved day 14HAL · Unilimdocument of 102 observations

50 percentAll patients presented with skin lesions, with genital or anal involvement in about half of the cases.

NigeriampoxHAL · Unilimdocument of 102 observations

28 casesAmong 35 suspected mpox cases in Rivers State, Nigeria, between October 21, 2021, and April 30, 2023, 28 (80%) required hospital admission.

Nigeriampoxobserved October 21, 2021 to April 30, 2023published 2025The Pan African medical journalPubMeddocument of 11 observations

124 confirmed_casesNigeria reported 124 confirmed mpox cases and zero deaths among confirmed cases in 2024.

Nigeriampoxobserved 2024Africa CDCdocument of 74 observations

78 %Seven (78%) of the nine mpox-related deaths were attributable to sepsis in Nigeria during the study period from Feb 1, 2022, to Jan 30, 2023.

Nigeriampox · sepsisobserved Feb 1, 2022, to Jan 30, 2023published 2023The Lancet. Infectious diseasesPubMeddocument of 11 observations

1,180 suspected_casesNigeria reported 1,180 suspected mpox cases in 2024, with 78 confirmed cases across 24 states and the Federal Capital Territory.

Nigeriampoxobserved 2024Africa CDCdocument of 147 observations

71 %At day 0, MPXV detection was more frequent from anus (30 [71%] of 42) than from blood (13 [29%] of 45), urine (nine [22%] of 41), or semen (13 [54%] of 24).

Nigeriampoxobserved day 0HAL · Unilimdocument of 102 observations

100 %In a Spanish study, MPXV was detected in saliva in 100% of patients.

NigeriampoxHAL · Unilimdocument of 102 observations

5 %At day 14, MPXV detection was observed in 1 (5%) of 21 blood samples.

NigeriampoxHAL · Unilimdocument of 102 observations

6 countriesAs of 05 September 2024, six countries were experiencing sustained human-to-human mpox transmission: the Democratic Republic of the Congo, Burundi, Nigeria, South Africa, Cote d’Ivoire, and the Central African Republic.

Afrique du Sud · Burundi · Nigeria · RDCmpoxobserved 05 September 2024Africa CDCdocument of 48 observations

3 casesAmong 35 suspected mpox cases in Rivers State, Nigeria, between October 21, 2021, and April 30, 2023, 3 (8.6%) resulted in death.

Nigeriampoxobserved October 21, 2021 to April 30, 2023published 2025The Pan African medical journalPubMeddocument of 11 observations

11 countriesSustained human-to-human mpox transmission was observed in 11 countries as of February 2025: DRC, Congo Republic, Central African Republic, Burundi, Kenya, Rwanda, Uganda, Zambia, Nigeria, Liberia, and Cote d’Ivoire.

Burundi · Kenya · Liberia · Nigeria · Ouganda · RDC · Rwanda · Zambiempoxobserved February 2025Africa CDCdocument of 110 observations

9 casesDuring the 2017/2018 Nigerian mpox outbreak, 9 out of 40 hospitalized mpox patients with known HIV status were people living with HIV.

Nigeriampoxobserved 2017/2018published 2023AIDS research and human retrovirusesPubMeddocument of 4 observations

6 patientsIn an English series, MPXV was detected in blood from six of seven patients at least once at the beginning of the disease.

NigeriampoxHAL · Unilimdocument of 102 observations

6 %Nine (6%) of the 160 patients with mpox died during the study period from Feb 1, 2022, to Jan 30, 2023 in Nigeria.

Nigeriampoxobserved Feb 1, 2022, to Jan 30, 2023published 2023The Lancet. Infectious diseasesPubMeddocument of 11 observations

22 %At day 0, MPXV detection was less frequent from urine (nine [22%] of 41) than from skin, anus, or throat.

Nigeriampoxobserved day 0HAL · Unilimdocument of 102 observations

19.8 CtMPXV viral load was significantly higher from skin lesions (Ct 19·8) than from throat (Ct 27·2), blood (Ct 32·8), or semen (Ct 27·8).

NigeriampoxHAL · Unilimdocument of 102 observations

71 %In this case series, a high proportion of MPXV-positive oral and anal swabs (71–77%) was found at diagnosis.

NigeriampoxHAL · Unilimdocument of 102 observations

88 %MPXV detection was more frequent from skin samples (44 of 50, 88%) than from blood (13 of 45, 29%), urine (9 of 41, 22%), or semen (13 of 24, 54%).

NigeriampoxHAL · Unilimdocument of 102 observations

22 %In this case series, a lower proportion of positive blood and urine samples (22–31%) was found at diagnosis.

NigeriampoxHAL · Unilimdocument of 102 observations

60 %Three-fifths of mpox cases had serological evidence of one or more STIs.

Nigeriampox · STIsobserved 2017-2019published 2023BMJ global healthPubMeddocument of 11 observations

22 %In a case series of 50 French male individuals with confirmed monkeypox, a lower proportion of positive blood and urine samples (22–31%) was found at diagnosis.

NigeriampoxHAL · Unilimdocument of 102 observations

20.8 %The case fatality rate among HIV-positive mpox cases was 20.8% (5/24).

Nigeriampox · VIH/sidaobserved 2017-2019published 2023BMJ global healthPubMeddocument of 11 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.